Latest Breaking News On - Renatod lopes - Page 1 : comparemela.com

Lower rates of access thrombosis for patients with CKD who receive daprodustat vs EPO

Lower rates of access thrombosis for patients with CKD who receive daprodustat vs EPO
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesRenatod lopesDuke university medical center

Optimal Antiplatelet Regimen in Bi-Risk ACS?

The large OPT-BIRISK trial adds important information to the complex puzzle of antithrombotic therapy after PCI for acute coronary syndrome, says one expert.

North carolinaUnited statesNoord hollandDuke universityRenatod lopesYaling hanAcademic research consortiumEuropean society of cardiologyGeneral hospitalNorthern theater commandEuropean societyEast asianMedscape cardiologyAmerican heart journalBleeding academic research consortiumLow risk subset

Mount Sinai and BCRI partner to improve cardiovascular health and education in Latin America

Icahn School of Medicine at Mount Sinai announced today that it has signed a memorandum of understanding with the Brazilian Clinical Research Institute (BCRI) to focus on advancing cardiovascular disease research, innovation, and medical education.

United statesNew yorkDenniss charneyLuis natelDeepakl bhattThomas almeidaMegan craigRenatod lopesBoard of trusteesBrazilian clinical research instituteIcahn school of medicine at mount sinaiMount sinaiMount sinai heartLatin americaValentin fuster professorCardiovascular medicine

Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial | Critical Care Medicine | JAMA

This open label clinical trial compares the effects of dexamethasone vs usual care on the number of days alive and free of mechanical ventilation at day 28 amon

United statesMoinhos de ventoJuazeiro do norteNereu ramosSanta catarinaDuke universityNorth carolinaEstado do rioSanta marcelinaEstado de mato grossoOswaldo cruzRio grande do sulFaculdade de medicinaEstado de pernambucoEspíto santoVila velha

Rivaroxaban Outmatched by VKAs for AF in Rheumatic Heart Disease

A striking and unexpected reduction in death with the use of predominantly warfarin was just one of the many surprises delivered by the INVICTUS trial at ESC 2022.

United statesNorth carolinaUnited kingdomNew delhiRhode islandBrown universityRenatod lopesGanesan karthikeyanStuartj connollyC michael gibsonAmerican college of cardiologyPopulation health research instituteDuke clinical research instituteHarvard medical schoolUniversity of liverpoolBaim institute for clinical research